Abstract: The present invention relates to a method of treating neurological conditions in a mammal by administering a hematopoietic growth factor such as granulocyte-colony stimulating factor (GCSF) and granulocyte-macrophage colony stimulating factor (GMCSF). The invention also provides methods of screening for compounds that bind to a GCSF or GMCSF receptor found on the surface of a neuronal cell; and which provides a neuroprotective, neuroproliferative and/or a STAT gene activation activity.

Abstract: The present invention relates to a method of treating a neurological condition in a mammal by administering at least one hematopoietic growth factor.

Abstract: The present invention relates to a method of treating a neurological condition in a mammal by administering at least one hematopoietic growth factor.

Abstract: An apparatus for estimating a property of a formation penetrated by a borehole, the apparatus having: a first electrode and a second electrode configured to couple to a characteristic impedance of a material disposed in the borehole; a third electrode configured with the first electrode to electrically couple to a characteristic impedance of the formation; a circuit element coupled to the first electrode and to the second electrode and having a characteristic impedance; a first sensing circuit coupled to the circuit element and configured to provide a first signal related to the impedance of the borehole material; and a second sensing circuit coupled to the first electrode and the third electrode and configured to provide a second signal related to the characteristic impedance of the formation; wherein the first signal and the second signal are used to estimate the property. A method is also provided.

Abstract: A method for outputting audio-visual media contents on a mobile electronic device is provided. The method may include receiving a request for the output of an audio-visual media content which is stored in a compressed format in a memory in a mobile electronic device; checking of whether a copy of the requested media content is stored in an uncompressed format in a nonvolatile memory in the device; and outputting the stored copy of the requested media content instead of the requested media content if a copy of the requested media content is stored in an uncompressed format in the nonvolatile memory in the device.

Abstract: The present invention relates to a screening method for the identification of protective substances which influence haemoglobin formation in neuronal, myocardial and/or skeletomuscular cells, as well as to recombinant constructs, host cells and transgenic animals for the implementation of this method. In addition, the present invention relates to a diagnostic method for the differential diagnosis of neurodegenerative and/or ischaemic diseases in mammals and the use of haemoglobin, a globin or a mutein or fusion protein thereof or a corresponding nucleic acid for the treatment of neurodegenerative and/or ischaemic diseases in mammals. The invention furthermore relates to constructs for gene therapy of such diseases.

Abstract: The present invention relates to a screening method for the identification of protective substances which influence haemoglobin formation in neuronal, myocardial and/or skeletomuscular cells, as well as to recombinant constructs, host cells and transgenic animals for the implementation of this method. In addition, the present invention relates to a diagnostic method for the differential diagnosis of neurodegenerative and/or ischaemic diseases in mammals and the use of haemoglobin, a globin or a mutein or fusion protein thereof or a corresponding nucleic acid for the treatment of neurodegenerative and/or ischaemic diseases in mammals. The invention furthermore relates to constructs for gene therapy of such diseases.

Abstract: The present invention relates to a method of treating a neurological condition in a mammal by administering at least one hematopoietic growth factor.

Abstract: The invention relates to screening methods and test systems for the in vitro diagnosis and detection of an increased risk of vasospasm in a patient. In addition, the invention describes the use of GAPDH and/or Hsc70 to diagnose an increased risk of vasospasm. Also described is a method for identifying a pharmaceutically active substance for the prevention and/or treatment of cerebral vasospasm and a method for screening a substance library to identify a pharmaceutically active substance for the prevention and/or treatment of cerebral vasospasm. Pharmaceutically active substances and combination preparations are also disclosed.

Abstract: The present invention relates to a method of treating a neurological condition in a mammal by administering at least one hematopoietic growth factor.

Abstract: The present invention relates to a method of treating a neurological condition in a mammal by administering at least one hematopoietic growth factor.

Abstract: The present invention relates to a method of treating a neurological condition in a mammal by administering at least one hematopoietic growth factor.

Abstract: The present invention relates to a method of treating a neurological condition in a mammal by administering at least one hematopoietic growth factor.

Abstract: The present invention relates to a method of treating a neurological condition in a mammal by administering at least one hematopoietic growth factor.

Abstract: The present invention relates to (i) DNA sequences, (ii) expression vectors comprising DNA sequences of the invention, (iv) host cells having the expression vectors of the invention, (v) gene products encoded by sequences of the invention, (vi) transgenic animals altered with respect to sequences of the invention, (vii) antibodies directed against gene products of the invention, (viii) methods for expressing and/or isolating gene products of the invention, (ix) the use of DNA sequences and/or gene products of the invention as drugs, (x) pharmaceutically active compounds and methods for preparing them and also uses of such compounds of the invention and (xi) nontherapeutic uses of DNA sequences and/or gene products of the invention.

Abstract: The present invention relates to a screening method for the identification of protective substances which influence haemoglobin formation in neuronal, myocardial and/or skeletomuscular cells, as well as to recombinant constructs, host cells and transgenic animals for the implementation of this method. In addition, the present invention relates to a diagnostic method for the differential diagnosis of neurodegenerative and/or ischaemic diseases in mammals and the use of haemoglobin, a globin or a mutein or fusion protein thereof or a corresponding nucleic acid for the treatment of neurodegenerative and/or ischaemic diseases in mammals. The invention furthermore relates to constructs for gene therapy of such diseases.

Abstract: The present invention relates to a method of treating a neurological condition in a mammal by administering at least one hematopoietic growth factor.

Abstract: The present invention relates to a method of treating neurological conditions in a mammal by administering a hematopoietic growth factor such as granulocyte-colony stimulating factor (GCSF) and granulocyte-macrophage colony stimulating factor (GMCSF). The invention also provides methods of screening for compounds that bind to a GCSF or GMCSF receptor found on the surface of a neuronal cell; and which provides a neuroprotective, neuroproliferative and/or a STAT gene activation activity.

Abstract: A method of determining resistivity of an earth formation through a conductive wellbore casing. The resistance of conductors within an armored electrical cable for a wellbore sonde is measured and the sonde is inserted into the wellbore. The sonde has a plurality of electrodes at axially spaced apart locations for electrically contacting the casing. A first electrical current is applied between a first electrode and a surface return electrode and a first current amplitude and phase is measured. A second phase shifted electrical current is applied between a second electrode and the surface return electrode and the second current amplitude and phase is measured. A first voltage amplitude and phase between a first pair of electrodes axially disposed between the first and second electrodes is measured, and a second voltage amplitude and phase between a second pair of electrodes axially disposed between the first and second electrodes is measured.

Abstract: In order to perform an ice-breaking operation more readily or with a defined geometry, an ice breaking aid is employed by virtue of which the ice is irradiated with high-frequency oscillations such as phonons or photons prior to the ice-breaking operation proper.